VAsopressin and STeroids in addition to Adrenaline in cardiac arrest-a randomized clinical trial

orrtälje Sjukhus, Tiohundra AB0 个研究点目标入组 82 人开始时间: 2019年7月17日最近更新: 2022年4月19日

适应症

试验速览

暂无简介。

•1. Provision of informed consent
•2. Symptoms and signs consistent with acute MI and ST elevation at the J-point in two
•contiguous leads (cut-points: >0.2mV in men and >0.15 mV in women in leads V2-V3 and/or
•>0.1 mV in other leads)
•3. Start of PCI, defined as when the guide wire is passed through the stenosis, less than 4 hours after symptom onset. Symptom onset defined as the time of the start of the pain that causes the call to the ambulance.
•4. TIMI flow grade 0 at angiography before PCI in left anterior descending coronary artery segment 6 or 7 without collaterals OR TIMI flow grade less than 3 in any infarct related main coronary arteries after PCI.
•5. Age 40-85, inclusive
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 80
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 80

•1. Cardiogenic chock, non-compensated acute heart failure and/or pulmonary oedema.
•2. Previous major vascular intervention within the last 4 weeks.
•3. History of an infarct in the same artery that is currently affected.
•4. Thrombolysis therapy prior to admission.

发起方

orrtälje Sjukhus, Tiohundra AB